FindTrial
Sign In

REASSURED evaluation of the Bioline™ Hepatitis C Virus (HCV) Point-of-care testing for diagnosing HCV infection in primary healthcare settings of Ghana

REASSURED evaluation of the Bioline™ Hepatitis C Virus (HCV) Point-of-care testing for diagnosing HCV infection in primary healthcare settings of Ghana

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202410837698664
Enrollment
400
Registered
2024-10-24
Start date
2024-11-04
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis C

Interventions

Bioline HCV

Sponsors

Abbott Rapid Diagnostics
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with clinician's request for HCV test Blood donors Staff of primary health clinics

Exclusion criteria

Exclusion criteria: Patients, blood donors and staff who do not give informed consent

Design outcomes

Primary

MeasureTime frame
Diagnostic performance of the test—

Secondary

MeasureTime frame
Usability and user experience—

Countries

Ghana

Contacts

Public ContactTivani Mashamba Thompson

Main supervisor

tivani.mashamba-thompson@up.ac.za+27784358283

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026